Global Biological Drugs Market Insights, Forecast to 2028

Report ID: 1653802 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Biological Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Biological Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Therapeutic Protein
        1.2.3 Monoclonal Antibody
        1.2.4 Vaccine
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Biological Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Biological Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Biological Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Biological Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Biological Drugs Sales by Region
        2.4.1 Global Biological Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Biological Drugs by Region (2023-2028)
    2.5 Global Biological Drugs Revenue by Region
        2.5.1 Global Biological Drugs Revenue by Region (2017-2022)
        2.5.2 Global Biological Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Biological Drugs Sales by Manufacturers
        3.1.1 Global Top Biological Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Biological Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biological Drugs in 2021
    3.2 Global Biological Drugs Revenue by Manufacturers
        3.2.1 Global Biological Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Biological Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Biological Drugs Revenue in 2021
    3.3 Global Biological Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Biological Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Biological Drugs Sales by Type
        4.1.1 Global Biological Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Biological Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Biological Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Biological Drugs Revenue by Type
        4.2.1 Global Biological Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Biological Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Biological Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Biological Drugs Price by Type
        4.3.1 Global Biological Drugs Price by Type (2017-2022)
        4.3.2 Global Biological Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Biological Drugs Sales by Application
        5.1.1 Global Biological Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Biological Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Biological Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Biological Drugs Revenue by Application
        5.2.1 Global Biological Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Biological Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Biological Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Biological Drugs Price by Application
        5.3.1 Global Biological Drugs Price by Application (2017-2022)
        5.3.2 Global Biological Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Biological Drugs Market Size by Type
        6.1.1 North America Biological Drugs Sales by Type (2017-2028)
        6.1.2 North America Biological Drugs Revenue by Type (2017-2028)
    6.2 North America Biological Drugs Market Size by Application
        6.2.1 North America Biological Drugs Sales by Application (2017-2028)
        6.2.2 North America Biological Drugs Revenue by Application (2017-2028)
    6.3 North America Biological Drugs Market Size by Country
        6.3.1 North America Biological Drugs Sales by Country (2017-2028)
        6.3.2 North America Biological Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Biological Drugs Market Size by Type
        7.1.1 Europe Biological Drugs Sales by Type (2017-2028)
        7.1.2 Europe Biological Drugs Revenue by Type (2017-2028)
    7.2 Europe Biological Drugs Market Size by Application
        7.2.1 Europe Biological Drugs Sales by Application (2017-2028)
        7.2.2 Europe Biological Drugs Revenue by Application (2017-2028)
    7.3 Europe Biological Drugs Market Size by Country
        7.3.1 Europe Biological Drugs Sales by Country (2017-2028)
        7.3.2 Europe Biological Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Biological Drugs Market Size by Type
        8.1.1 Asia Pacific Biological Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Biological Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Biological Drugs Market Size by Application
        8.2.1 Asia Pacific Biological Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Biological Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Biological Drugs Market Size by Region
        8.3.1 Asia Pacific Biological Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Biological Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Biological Drugs Market Size by Type
        9.1.1 Latin America Biological Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Biological Drugs Revenue by Type (2017-2028)
    9.2 Latin America Biological Drugs Market Size by Application
        9.2.1 Latin America Biological Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Biological Drugs Revenue by Application (2017-2028)
    9.3 Latin America Biological Drugs Market Size by Country
        9.3.1 Latin America Biological Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Biological Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Biological Drugs Market Size by Type
        10.1.1 Middle East and Africa Biological Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Biological Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Biological Drugs Market Size by Application
        10.2.1 Middle East and Africa Biological Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Biological Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Biological Drugs Market Size by Country
        10.3.1 Middle East and Africa Biological Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Biological Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bristol-Myers Squibb
        11.1.1 Bristol-Myers Squibb Corporation Information
        11.1.2 Bristol-Myers Squibb Overview
        11.1.3 Bristol-Myers Squibb Biological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bristol-Myers Squibb Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bristol-Myers Squibb Recent Developments
    11.2 Eli Lilly
        11.2.1 Eli Lilly Corporation Information
        11.2.2 Eli Lilly Overview
        11.2.3 Eli Lilly Biological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Eli Lilly Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Eli Lilly Recent Developments
    11.3 Takeda
        11.3.1 Takeda Corporation Information
        11.3.2 Takeda Overview
        11.3.3 Takeda Biological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Takeda Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Takeda Recent Developments
    11.4 Pfizer
        11.4.1 Pfizer Corporation Information
        11.4.2 Pfizer Overview
        11.4.3 Pfizer Biological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Pfizer Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Pfizer Recent Developments
    11.5 Amgen
        11.5.1 Amgen Corporation Information
        11.5.2 Amgen Overview
        11.5.3 Amgen Biological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Amgen Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Amgen Recent Developments
    11.6 F. Hoffmann-La Roche
        11.6.1 F. Hoffmann-La Roche Corporation Information
        11.6.2 F. Hoffmann-La Roche Overview
        11.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 F. Hoffmann-La Roche Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 F. Hoffmann-La Roche Recent Developments
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Corporation Information
        11.7.2 Johnson & Johnson Overview
        11.7.3 Johnson & Johnson Biological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Johnson & Johnson Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Johnson & Johnson Recent Developments
    11.8 Merck
        11.8.1 Merck Corporation Information
        11.8.2 Merck Overview
        11.8.3 Merck Biological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Merck Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Merck Recent Developments
    11.9 Abbott Laboratories
        11.9.1 Abbott Laboratories Corporation Information
        11.9.2 Abbott Laboratories Overview
        11.9.3 Abbott Laboratories Biological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Abbott Laboratories Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Abbott Laboratories Recent Developments
    11.10 Baxter
        11.10.1 Baxter Corporation Information
        11.10.2 Baxter Overview
        11.10.3 Baxter Biological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Baxter Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Baxter Recent Developments
    11.11 Novartis
        11.11.1 Novartis Corporation Information
        11.11.2 Novartis Overview
        11.11.3 Novartis Biological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Novartis Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Novartis Recent Developments
    11.12 Biogen
        11.12.1 Biogen Corporation Information
        11.12.2 Biogen Overview
        11.12.3 Biogen Biological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Biogen Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Biogen Recent Developments
    11.13 GlaxoSmithKline
        11.13.1 GlaxoSmithKline Corporation Information
        11.13.2 GlaxoSmithKline Overview
        11.13.3 GlaxoSmithKline Biological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 GlaxoSmithKline Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 GlaxoSmithKline Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Biological Drugs Industry Chain Analysis
    12.2 Biological Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Biological Drugs Production Mode & Process
    12.4 Biological Drugs Sales and Marketing
        12.4.1 Biological Drugs Sales Channels
        12.4.2 Biological Drugs Distributors
    12.5 Biological Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Biological Drugs Industry Trends
    13.2 Biological Drugs Market Drivers
    13.3 Biological Drugs Market Challenges
    13.4 Biological Drugs Market Restraints
14 Key Findings in The Global Biological Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Biological Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Therapeutic Protein
    Table 3. Major Manufacturers of Monoclonal Antibody
    Table 4. Major Manufacturers of Vaccine
    Table 5. Major Manufacturers of Others
    Table 6. Global Biological Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Biological Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Biological Drugs Sales by Region (2017-2022) & (K MT)
    Table 9. Global Biological Drugs Sales Market Share by Region (2017-2022)
    Table 10. Global Biological Drugs Sales by Region (2023-2028) & (K MT)
    Table 11. Global Biological Drugs Sales Market Share by Region (2023-2028)
    Table 12. Global Biological Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Biological Drugs Revenue Market Share by Region (2017-2022)
    Table 14. Global Biological Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Biological Drugs Revenue Market Share by Region (2023-2028)
    Table 16. Global Biological Drugs Sales by Manufacturers (2017-2022) & (K MT)
    Table 17. Global Biological Drugs Sales Share by Manufacturers (2017-2022)
    Table 18. Global Biological Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Biological Drugs Revenue Share by Manufacturers (2017-2022)
    Table 20. Biological Drugs Price by Manufacturers (2017-2022) &(USD/MT)
    Table 21. Global Biological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Biological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Drugs as of 2021)
    Table 23. Biological Drugs Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Biological Drugs Product Offered
    Table 25. Date of Manufacturers Enter into Biological Drugs Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Biological Drugs Sales by Type (2017-2022) & (K MT)
    Table 28. Global Biological Drugs Sales by Type (2023-2028) & (K MT)
    Table 29. Global Biological Drugs Sales Share by Type (2017-2022)
    Table 30. Global Biological Drugs Sales Share by Type (2023-2028)
    Table 31. Global Biological Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Biological Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Biological Drugs Revenue Share by Type (2017-2022)
    Table 34. Global Biological Drugs Revenue Share by Type (2023-2028)
    Table 35. Biological Drugs Price by Type (2017-2022) & (USD/MT)
    Table 36. Global Biological Drugs Price Forecast by Type (2023-2028) & (USD/MT)
    Table 37. Global Biological Drugs Sales by Application (2017-2022) & (K MT)
    Table 38. Global Biological Drugs Sales by Application (2023-2028) & (K MT)
    Table 39. Global Biological Drugs Sales Share by Application (2017-2022)
    Table 40. Global Biological Drugs Sales Share by Application (2023-2028)
    Table 41. Global Biological Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Biological Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Biological Drugs Revenue Share by Application (2017-2022)
    Table 44. Global Biological Drugs Revenue Share by Application (2023-2028)
    Table 45. Biological Drugs Price by Application (2017-2022) & (USD/MT)
    Table 46. Global Biological Drugs Price Forecast by Application (2023-2028) & (USD/MT)
    Table 47. North America Biological Drugs Sales by Type (2017-2022) & (K MT)
    Table 48. North America Biological Drugs Sales by Type (2023-2028) & (K MT)
    Table 49. North America Biological Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Biological Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Biological Drugs Sales by Application (2017-2022) & (K MT)
    Table 52. North America Biological Drugs Sales by Application (2023-2028) & (K MT)
    Table 53. North America Biological Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Biological Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Biological Drugs Sales by Country (2017-2022) & (K MT)
    Table 56. North America Biological Drugs Sales by Country (2023-2028) & (K MT)
    Table 57. North America Biological Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Biological Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Biological Drugs Sales by Type (2017-2022) & (K MT)
    Table 60. Europe Biological Drugs Sales by Type (2023-2028) & (K MT)
    Table 61. Europe Biological Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Biological Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Biological Drugs Sales by Application (2017-2022) & (K MT)
    Table 64. Europe Biological Drugs Sales by Application (2023-2028) & (K MT)
    Table 65. Europe Biological Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Biological Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Biological Drugs Sales by Country (2017-2022) & (K MT)
    Table 68. Europe Biological Drugs Sales by Country (2023-2028) & (K MT)
    Table 69. Europe Biological Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Biological Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Biological Drugs Sales by Type (2017-2022) & (K MT)
    Table 72. Asia Pacific Biological Drugs Sales by Type (2023-2028) & (K MT)
    Table 73. Asia Pacific Biological Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Biological Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Biological Drugs Sales by Application (2017-2022) & (K MT)
    Table 76. Asia Pacific Biological Drugs Sales by Application (2023-2028) & (K MT)
    Table 77. Asia Pacific Biological Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Biological Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Biological Drugs Sales by Region (2017-2022) & (K MT)
    Table 80. Asia Pacific Biological Drugs Sales by Region (2023-2028) & (K MT)
    Table 81. Asia Pacific Biological Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Biological Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Biological Drugs Sales by Type (2017-2022) & (K MT)
    Table 84. Latin America Biological Drugs Sales by Type (2023-2028) & (K MT)
    Table 85. Latin America Biological Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Biological Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Biological Drugs Sales by Application (2017-2022) & (K MT)
    Table 88. Latin America Biological Drugs Sales by Application (2023-2028) & (K MT)
    Table 89. Latin America Biological Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Biological Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Biological Drugs Sales by Country (2017-2022) & (K MT)
    Table 92. Latin America Biological Drugs Sales by Country (2023-2028) & (K MT)
    Table 93. Latin America Biological Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Biological Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Biological Drugs Sales by Type (2017-2022) & (K MT)
    Table 96. Middle East and Africa Biological Drugs Sales by Type (2023-2028) & (K MT)
    Table 97. Middle East and Africa Biological Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Biological Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Biological Drugs Sales by Application (2017-2022) & (K MT)
    Table 100. Middle East and Africa Biological Drugs Sales by Application (2023-2028) & (K MT)
    Table 101. Middle East and Africa Biological Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Biological Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Biological Drugs Sales by Country (2017-2022) & (K MT)
    Table 104. Middle East and Africa Biological Drugs Sales by Country (2023-2028) & (K MT)
    Table 105. Middle East and Africa Biological Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Biological Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Bristol-Myers Squibb Corporation Information
    Table 108. Bristol-Myers Squibb Description and Major Businesses
    Table 109. Bristol-Myers Squibb Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 110. Bristol-Myers Squibb Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Bristol-Myers Squibb Recent Developments
    Table 112. Eli Lilly Corporation Information
    Table 113. Eli Lilly Description and Major Businesses
    Table 114. Eli Lilly Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 115. Eli Lilly Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Eli Lilly Recent Developments
    Table 117. Takeda Corporation Information
    Table 118. Takeda Description and Major Businesses
    Table 119. Takeda Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 120. Takeda Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Takeda Recent Developments
    Table 122. Pfizer Corporation Information
    Table 123. Pfizer Description and Major Businesses
    Table 124. Pfizer Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 125. Pfizer Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Pfizer Recent Developments
    Table 127. Amgen Corporation Information
    Table 128. Amgen Description and Major Businesses
    Table 129. Amgen Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 130. Amgen Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Amgen Recent Developments
    Table 132. F. Hoffmann-La Roche Corporation Information
    Table 133. F. Hoffmann-La Roche Description and Major Businesses
    Table 134. F. Hoffmann-La Roche Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 135. F. Hoffmann-La Roche Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. F. Hoffmann-La Roche Recent Developments
    Table 137. Johnson & Johnson Corporation Information
    Table 138. Johnson & Johnson Description and Major Businesses
    Table 139. Johnson & Johnson Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 140. Johnson & Johnson Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Johnson & Johnson Recent Developments
    Table 142. Merck Corporation Information
    Table 143. Merck Description and Major Businesses
    Table 144. Merck Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 145. Merck Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Merck Recent Developments
    Table 147. Abbott Laboratories Corporation Information
    Table 148. Abbott Laboratories Description and Major Businesses
    Table 149. Abbott Laboratories Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 150. Abbott Laboratories Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Abbott Laboratories Recent Developments
    Table 152. Baxter Corporation Information
    Table 153. Baxter Description and Major Businesses
    Table 154. Baxter Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 155. Baxter Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Baxter Recent Developments
    Table 157. Novartis Corporation Information
    Table 158. Novartis Description and Major Businesses
    Table 159. Novartis Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 160. Novartis Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Novartis Recent Developments
    Table 162. Biogen Corporation Information
    Table 163. Biogen Description and Major Businesses
    Table 164. Biogen Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 165. Biogen Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Biogen Recent Developments
    Table 167. GlaxoSmithKline Corporation Information
    Table 168. GlaxoSmithKline Description and Major Businesses
    Table 169. GlaxoSmithKline Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 170. GlaxoSmithKline Biological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. GlaxoSmithKline Recent Developments
    Table 172. Key Raw Materials Lists
    Table 173. Raw Materials Key Suppliers Lists
    Table 174. Biological Drugs Distributors List
    Table 175. Biological Drugs Customers List
    Table 176. Biological Drugs Market Trends
    Table 177. Biological Drugs Market Drivers
    Table 178. Biological Drugs Market Challenges
    Table 179. Biological Drugs Market Restraints
    Table 180. Research Programs/Design for This Report
    Table 181. Key Data Information from Secondary Sources
    Table 182. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biological Drugs Product Picture
    Figure 3. Global Biological Drugs Market Share by Type in 2021 & 2028
    Figure 3. Therapeutic Protein Product Picture
    Figure 4. Monoclonal Antibody Product Picture
    Figure 5. Vaccine Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Biological Drugs Market Share by Application in 2021 & 2028
    Figure 8. Hospitals
    Figure 9. Ambulatory Surgical Centers
    Figure 10. Others
    Figure 11. Biological Drugs Report Years Considered
    Figure 12. Global Biological Drugs Sales 2017-2028 (K MT)
    Figure 13. Global Biological Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Biological Drugs Revenue 2017-2028 (US$ Million)
    Figure 15. Global Biological Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Biological Drugs Sales Market Share by Region (2017-2022)
    Figure 17. Global Biological Drugs Sales Market Share by Region (2023-2028)
    Figure 18. North America Biological Drugs Sales YoY (2017-2028) & (K MT)
    Figure 19. North America Biological Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Biological Drugs Sales YoY (2017-2028) & (K MT)
    Figure 21. Europe Biological Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Biological Drugs Sales YoY (2017-2028) & (K MT)
    Figure 23. Asia-Pacific Biological Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Biological Drugs Sales YoY (2017-2028) & (K MT)
    Figure 25. Latin America Biological Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Biological Drugs Sales YoY (2017-2028) & (K MT)
    Figure 27. Middle East & Africa Biological Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Biological Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Biological Drugs in the World: Market Share by Biological Drugs Revenue in 2021
    Figure 30. Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Biological Drugs Sales Market Share by Type (2017-2028)
    Figure 32. Global Biological Drugs Revenue Market Share by Type (2017-2028)
    Figure 33. Global Biological Drugs Sales Market Share by Application (2017-2028)
    Figure 34. Global Biological Drugs Revenue Market Share by Application (2017-2028)
    Figure 35. North America Biological Drugs Sales Market Share by Type (2017-2028)
    Figure 36. North America Biological Drugs Revenue Market Share by Type (2017-2028)
    Figure 37. North America Biological Drugs Sales Market Share by Application (2017-2028)
    Figure 38. North America Biological Drugs Revenue Market Share by Application (2017-2028)
    Figure 39. North America Biological Drugs Sales Share by Country (2017-2028)
    Figure 40. North America Biological Drugs Revenue Share by Country (2017-2028)
    Figure 41. U.S. Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Biological Drugs Sales Market Share by Type (2017-2028)
    Figure 44. Europe Biological Drugs Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Biological Drugs Sales Market Share by Application (2017-2028)
    Figure 46. Europe Biological Drugs Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Biological Drugs Sales Share by Country (2017-2028)
    Figure 48. Europe Biological Drugs Revenue Share by Country (2017-2028)
    Figure 49. Germany Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. France Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Biological Drugs Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Biological Drugs Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Biological Drugs Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Biological Drugs Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Biological Drugs Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Biological Drugs Revenue Share by Region (2017-2028)
    Figure 60. China Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. India Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Biological Drugs Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Biological Drugs Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Biological Drugs Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Biological Drugs Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Biological Drugs Sales Share by Country (2017-2028)
    Figure 75. Latin America Biological Drugs Revenue Share by Country (2017-2028)
    Figure 76. Mexico Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Biological Drugs Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Biological Drugs Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Biological Drugs Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Biological Drugs Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Biological Drugs Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Biological Drugs Revenue Share by Country (2017-2028)
    Figure 85. Turkey Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Biological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 88. Biological Drugs Value Chain
    Figure 89. Biological Drugs Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bristol-Myers Squibb
Eli Lilly
Takeda
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline
Frequently Asked Questions
Biological Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biological Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biological Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Gypsum Wallboard

Gypsum Wallboard market is segmented by Type and by Application. Players, stakeholders, and other ... Read More